Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination

Autor:	Fontana, A., Guido Bocci, Fontana, E., Galli, C., Loupakis, F., Landi, L., Lo Dico, M., Mazzoni, E., Barsanti, G., Alfredo Falcone
Jazyk:	angličtina
Rok vydání:	2006
Zdroj:	Università di Pisa-IRIS
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44e2809b40d1a1a00de8b7fb86f80bcd http://hdl.handle.net/11568/105172 Zobrazit plný text záznamu